Article Information
vol. 31 no. 166
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 19, 2022
- Accepted May 30, 2022
- Published online October 19, 2022.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Catia Cilloniz1,2,3⇑,
- Carlos M. Luna4,
- Juan Carlos Hurtado5,
- María Ángeles Marcos5 and
- Antoni Torres1,2
- 1Pneumology Dept, Respiratory Institute, Hospital Clinic of Barcelona - Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB), Barcelona, Spain
- 2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (Ciberes), Barcelona, Spain
- 3Faculty of Health Sciences, Continental University, Huancayo, Peru
- 4Pneumology Division, Hospital of Clínicas, Faculty of Medicine, Universidad de Buenos Aires, Buenos Aires, Argentina
- 5Dept of Microbiology, Hospital Clinic, Universitat de Barcelona, ISGlobal, Barcelona, Spain
- Corresponding author: Catia Cilloniz (catiacilloniz{at}yahoo.com)
Article usage
Altmetrics
Vol 31 Issue 166
Table of Contents
Respiratory viruses: their importance and lessons learned from COVID-19
Jump To
- Article
- Abstract
- Abstract
- Introduction
- The impact of LRVIs
- Respiratory virus transmission and transmissibility
- Transmissibility
- Host risk factors for severe lung viral infection
- The role of biomarkers in severe lung viral infections
- Inflammatory biomarkers
- Haematological and biochemical biomarkers
- Microbiologic diagnosis
- Antiviral therapy
- Corticosteroids: benefit or harm
- Prevention
- Conclusion
- Acknowledgments
- Footnotes
- References
- Figures & Data
- Info & Metrics